Across TCGA patient cohorts, TRAV17 mutation is significantly associated with the immune_cell of many other genes, with 2 significant associations in total. HNSC shows the largest number of these associations.

The most reproducible TRAV17-associated genes across cancer lineages are CD4+ Tcm and GMP. Each is linked with TRAV17 in more than 1 cancer types. Because this analysis shows association rather than direction, both TRAV17-to-partner and partner-to-TRAV17 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (TRAV17→partner) and Y-score (partner→TRAV17) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
HNSC	CD4+ Tcm →	+0.013	+5.468	<.001	.043	3	1
LUSC	GMP →	+0.075	+3.264	<.001	.046	3	1

Each partner links to its Q-omics profile. Showing the 2 strongest of 2 associations by consensus.

Exploration

TRAV17 survival (RNA) · tumor vs normal (RNA) · all TRAV17 data types